• Research
  • Discovery
  • Development
WIRF is one of Australia's leading organisations that is dedicated to improving the health of women and infants.

Paul Cohen

Paul Cohen

Consultant Gynaecologist, WA Gynaecological Cancer Service & Director of Gynaecological Cancer Research, SJOG
  • Paul Cohen is a Consultant Gynaecologist with the WA Gynaecological Cancer Service, King Edward Memorial Hospital and Director of Gynaecological Cancer Research at St John of God Subiaco Hospital. He is a Clinical Senior Lecturer at the University of Western Australia. He completed his medical degree at the University of Oxford and subsequently undertook specialist training in obstetrics and gynaecology in Auckland, New Zealand.

    He undertook full time research in the molecular biology of ovarian stromal tumours, for which he was awarded a Doctorate in Medicine by the University of Auckland in 2011. He is the Coordinating Principal Investigator of the WA Gynaecological Oncology Biobank Project. He organized and chaired Western Australia’s inaugural BRCA Information Day in May 2016.

    His group conducts translational research, population-based studies utilising Western Australian linked health data, research into quality of life in women at high risk for ovarian cancer and health behaviour in endometrial cancer survivors, and clinical trials in gynaecological surgery for pre-invasive and malignant disease. His research into outcomes following treatment for screen-detected cervical adenocarcinoma in situ has led to new practice recommendations in the 2017 revised National Cervical Screening Program guidelines.
  • Paul’s group conducts translational research, population-based studies utilizing Western Australian linked health data, research into quality of life in women at high risk for ovarian cancer and health behaviour in endometrial cancer survivors, and clinical trials in gynaecological surgery for pre-invasive and malignant disease.

    His research into outcomes following treatment for screen-detected cervical adenocarcinoma in situ has led to new practice recommendations in the 2017 revised National Cervical Screening Program guidelines.
    • EXCISE Study – Excisional Treatment Comparison of In Situ Endocervical adenocarcinoma
    • Blood based biomarkers to predict recurrence in ovarian cancer
    • Sexual Healing: A Randomised, Controlled Trial on the Effect of Pre-Operative Sexual Counselling on Sexuality and Quality of Life after Risk-Reducing Salpingo-oophorectomy
    • Circulating microRNAs to detect early stage ovarian cancer
    • Behavioural Intervention Trial to Improve Physical Activity in Cancer Survivors at Cardiovascular Risk
    • Exploring attitudes to conception in partners and young women with gynaecological cancers treated by fertility sparing surgery
    • TRACEBACK  - Finding BRCA1 and BRCA2 mutations in women with ovarian cancer that predate changes to genetic testing guidelines
    • Single cell genomic profiling of tubo-ovarian high grade serous carcinomas following neoadjuvant chemotherapy
    • Histological tumour regression following neoadjuvant chemotherapy for tubo-ovarian high grade serous carcinoma
    • Effects of HPV vaccination on the development of cervical abnormalities for Aboriginal women: A Western Australian study
    • Gynaecological Cancers in Western Australia: A Program of Research Utilising Linked Health Data
    • Doctor of Medicine (MD) - University of Auckland, December 2010
    • Fellow of the Royal Australian and New Zealand College of Obstetrics and Gynaecology (FRANZCOG), July 2010
    • Member of the Royal Australian and New Zealand College of Obstetrics and Gynaecology (MRANZCOG), October 2007
    • Diploma in Obstetrics and Medical Gynaecology, University of Auckland, June 2002
    • MA in Physiological Sciences, University of Oxford, July 2001
    • Bachelor in Medicine and Bachelor in Surgery (BM BCh), University of Oxford, July 2000
    • BA in Physiological Sciences, University of Oxford, July 1997
    • Winner of the Best Abstract Prize (April 2016) Australia New Zealand Gynaecological Oncology Group Scientific Meeting Sydney
    • Keith Free Prize (July 2011) for best Fellow’s presentation at the Australian Society of Gynaecologic Oncologists Scientific Meeting Queenstown, New Zealand
    • Ida Mary Henderson Scholarship (Oct 1998) for academic and clinical excellence
    • The Hobson Memorial Scholarship (May 1998) for academic and clinical excellence
    • Roche Prize in Laboratory Medicine (Mar 1998)
    • Dixon Scholarship (Oct 1997) for academic excellence
    • The Wronker Prize for outstanding performance in Finals (July 1997)
    • The Gurney Travel Prize (Oct 1999)
    • University of Oxford Open Exhibition (Oct 1995) top decile in first BM, part 1.
    1. Hardcastle, S. J. and P. A. Cohen (2017). "Effective Physical Activity Promotion to Survivors of Cancer Is Likely to Be Home Based and to Require Oncologist Participation." Journal of Clinical Oncology. Published online September 15th 2017
    2. Codde E, Munro A, Stewart C.J.R, Spilsbury K, Bowen S, Codde J, Steel N, Leung Y, Tan J, Salfinger S.G, Mohan G.R, Cohen P.A. Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intraepithelial neoplasia grades 2 and 3 [CIN 2/3]). British Journal of Obstetrics and Gynaecology. Published ahead of print July 5th 2017.
    3. Munro A, Codde J, Spilsbury K, Steel N, Stewart CJ, Salfinger SG, Tan J, Mohan GR, Leung Y, Semmens J, O'Leary P, Williams V, Cohen PA. Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma-in-situ. Am J Obstet Gynecol. 2017 Mar;216(3): 272.e1-272.e7
    4. Paul A. Cohen, Nicola Flowers, Stephen Tong, Natalie Hannan, Mark D. Pertile and Lisa Hui. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening. BMC Medicine 2016 Aug 24;14(1):126
    5. Cohen PA, Nichols CB, Schofield L, Van Der Werf S, Pachter N. Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing. Int J Gynecol Cancer 2016 Jun;26(5):892-7
For over 40 years, WIRF has conducted and supported research to improve the health of women and infants.

Research Themes

Sign up to our newsletter

Get the latest announcements, news and updates.

Contact details

Women and Infants Research Foundation
Carson House, King Edward Memorial Hospital
374 Bagot Road, Subiaco, WA 6008

Telephone: 08 6458 1437
Fax: 08 6458 1642
Email: info@wirf.com.au

Social Media